|
DLG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62636570877339E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.65882887823454E-12 |
| Normal-vs-Stage2 |
4.56019999994783E-06 |
| Normal-vs-Stage3 |
1.92734717074927E-13 |
| Normal-vs-Stage4 |
2.21411777800995E-12 |
| Stage1-vs-Stage2 |
3.594000E-01 |
| Stage1-vs-Stage3 |
6.135800E-02 |
| Stage1-vs-Stage4 |
4.083500E-03 |
| Stage2-vs-Stage3 |
2.940500E-02 |
| Stage2-vs-Stage4 |
5.237500E-03 |
| Stage3-vs-Stage4 |
3.698000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.33146835171283E-15 |
| Normal-vs-AfricanAmerican |
1.448380E-04 |
| Normal-vs-Asian |
4.15260048569621E-10 |
| Caucasian-vs-AfricanAmerican |
2.774200E-01 |
| Caucasian-vs-Asian |
9.220400E-01 |
| AfricanAmerican-vs-Asian |
2.755200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.16537940093076E-13 |
| Normal-vs-Female |
1.68354219454159E-12 |
| Male-vs-Female |
4.496400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.57409673973552E-12 |
| Normal-vs-Age(41-60Yrs) |
1.03309583110445E-11 |
| Normal-vs-Age(61-80Yrs) |
9.605205519847E-12 |
| Normal-vs-Age(81-100Yrs) |
2.642300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.726400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.865800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.209400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.821600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.812000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.029600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.597500E-04 |
| Classical-VS-Follicular |
4.416000E-02 |
| Classical-VS-Other |
6.674600E-01 |
| Classical-VS-Normal |
5.9566995780358E-10 |
| Tall-VS-Follicular |
3.55140000000143E-05 |
| Tall-VS-Other |
2.411400E-01 |
| Tall-VS-Normal |
2.90878432451791E-13 |
| Follicular-VS-Other |
3.332800E-01 |
| Follicular-VS-Normal |
3.54820000000311E-05 |
| Other-VS-Normal |
2.635800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.00509633738488E-11 |
| Normal-vs-N1 |
1.81799020282369E-12 |
| N0-vs-N1 |
3.082900E-03 |
|
|
